{
    "clinical_study": {
        "@rank": "153020", 
        "arm_group": {
            "arm_group_label": "Experimental: Group A", 
            "arm_group_type": "Experimental", 
            "description": "ROX Coupler + continuing standard antihypertensive medications"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this registry is to evaluate the safety and performance of the ROX COUPLER in\n      patients with treatment-resistant or uncontrolled hypertension."
        }, 
        "brief_title": "Registry to Evaluate the ROX COUPLER in Patients With Resistant or Uncontrolled Hypertension", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypertension", 
            "Blood Pressure, High", 
            "Blood Pressure, Resistant", 
            "Blood Pressure, Uncontrolled"
        ], 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of resistant or uncontrolled hypertension must be made on the basis of\n             current findings, medical history, and physical examination.\n\n        Exclusion Criteria:\n\n          -  Any serious medical condition that may adversely affect the patient's safety, limit\n             the subject's ability to participate in the registry, comply with follow-up\n             requirements, or impact the scientific integrity of the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01885390", 
            "org_study_id": "RH-03"
        }, 
        "intervention": {
            "arm_group_label": "Experimental: Group A", 
            "description": "The COUPLER will be used to create an anastomosis in the iliac region (between the iliac artery and vein).", 
            "intervention_name": "ROX COUPLER", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hypertension", 
            "High blood pressure", 
            "Resistant blood pressure", 
            "Uncontrolled blood pressure"
        ], 
        "lastchanged_date": "April 17, 2014", 
        "location": [
            {
                "contact": {
                    "email": "steve.furniss@esht.nhs.uk", 
                    "last_name": "Steve Furniss, MD"
                }, 
                "contact_backup": {
                    "email": "sarah.bridgland@esht.uk", 
                    "last_name": "Sarah Bridgland, BS"
                }, 
                "facility": {
                    "address": {
                        "city": "East Sussex", 
                        "country": "United Kingdom", 
                        "zip": "BN21 2UD"
                    }, 
                    "name": "East Sussex Healthcare NHS Trust"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "m.d.lobo@qmul.ac.uk", 
                    "last_name": "Mel Lobo, MD", 
                    "phone": "020 7882 3416"
                }, 
                "contact_backup": {
                    "email": "a.zak@qmul.ac.uk", 
                    "last_name": "Anne Zak, RN", 
                    "phone": "020 7882 5660"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "EC1M 6BQ"
                    }, 
                    "name": "Queen Mary University of London"
                }, 
                "investigator": {
                    "last_name": "Mel Lobo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "ROX CONTROL HTN Registry: To Evaluate the ROX Coupler in Patients With Resistant or Uncontrolled Hypertension", 
        "overall_official": {
            "affiliation": "Queen Mary University of London", 
            "last_name": "Mel Lobo, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "England: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in mean ambulatory daytime systolic blood pressure at six months as compared to Baseline.", 
            "measure": "Change in ambulatory daytime mean systolic blood pressure", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01885390"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Change in mean ambulatory daytime diastolic blood pressure at six months as compared to Baseline.", 
            "measure": "Change in ambulatory daytime mean diastolic blood pressure", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 6 months"
        }, 
        "source": "ROX Medical, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ROX Medical, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}